Financial Snapshot

Revenue
$38.21K
TTM
Gross Margin
50.0%
TTM
Net Earnings
$407.9K
TTM
Current Assets
Q1 2024
Current Liabilities
Q1 2024
Current Ratio
0.87%
Q1 2024
Total Assets
Q1 2024
Total Liabilities
Q1 2024
Book Value
-$1.441M
Q1 2024
Cash
Q1 2024
P/E
0.006596
Nov 27, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2012 2011 2007 2006 2005 2004 2003 2002 2001 2000

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $2.6906 Thousand

About Real Brands, Inc.

Real Brands, Inc. engages in the provision of a hemp-derived cannabinol (CBD) market. The company is headquartered in Pompano Beach, Florida and currently employs 1 full-time employees. The company went IPO on 2005-10-10. The Company’s primary business is hemp cannabinoids (CBD) oil/isolate extraction, wholesaling of CBD oils and isolate, and manufacturing, production and sales of hemp-derived CBD consumer brands and white label products. The company is extracting and refining oils and compounds of interest from hemp cultivars using its processing technology and methodology. Its products consist of oils, tinctures, capsules, topicals, edibles, and pet products. The firm acquires and/or develops brands that CBD and minor cannabinoids are complementary ingredients, and which are conducive to hemp derived infusion or micro encapsulation that is chocolates, cosmetics, edibles, drinks, sprays, tinctures, sub-lingual strips, cooking condiments, powders, vapes, and others. The Company’s HALO.5 simulated moving bed chromatography system (SMB) is an integrated six-column SMB system designed for isolation and purification of chemical compounds.

Industry: Beverages Peers: TALPHERA, INC. Elicio Therapeutics, Inc. Cocrystal Pharma, Inc. Clever Leaves Holdings Inc. ELITE PHARMACEUTICALS INC /NV/ Processa Pharmaceuticals, Inc. JOHNSON & JOHNSON Landos Biopharma, Inc. NutriBand Inc.